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ABSTRACT 
Photoactivated psoralens and other agents that form DNA interstrand crosslinks 
are highly cytotoxic and are useful in treating a range of diseases, including vitiligo, 
psoriasis, and some forms of cancer. Unlike many lesions that damage only one strand of 
the duplex DNA, DNA interstrand crosslinks form covalent bonds with both strands. 
Thus, repairing these lesions is complicated both by the lack of an undamaged strand to 
serve as a template for resynthesis following excision ,as well as the potential to form 
double strand breaks if both strands are incised. A number of models have proposed that 
repair is likely to couple nucleotide excision repair with other repair pathways such as 
recombination, and/or translesion synthesis. However, several aspects of these models 
remain speculative, and how these medically relevant lesions are repaired by cells still 
remains elusive. In this study, I use Escherichia coli as a model organism to characterize 
which gene products contribute to survival in the presence of psoralen-induced DNA 
interstrand crosslinks. 
In Chapter II, I demonstrate that although nucleotide excision repair initiates 
repair, not all subunits contribute equally to survival. Notably, uvrC is less sensitive to 
psoralen-induced damage than either uvrA or uvrB. I found that Cho, an alternative 
endonuclease, accounts for the increased resistance of uvrC mutants and contributes to 
survival in the presence of UvrABC. Cho was not required following angelicin treatment, 
a psoralen derivative that only forms monoadducts, suggesting that Cho function is 
specific for interstrand crosslink repair. However, Cho, by itself, is not required for the 
initial incision and only modestly enhances the rate that psoralen crosslinks are incised   
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in vivo.  
Following incision, many of the intermediates in the repair process remain 
speculative.  In Chapter III, I examine how recombination and translesion synthesis 
mutants contribute to survival of psoralen-induced damage. I show that both recBC and 
recF contribute to survival, but that neither mutant is as hypersensitive as recA, 
potentially suggesting that pathways involving either single strand gaps or double strand 
break intermediates can occur during repair. Finally, I show that Polymerase V is 
responsible for the translesion synthesis that contributes to survival in the case of 
psoralen-induced damage in E.coli.  
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CHAPTER I 
Psoralens are photoactive chemicals that belong to a family of plant chemicals 
called furocoumarins that naturally occur in the roots, leaves, and fruits of five plant 
families:  Umbelliferae, Rutaceae, Moraceae, Leguminosae and Orchidaceous (1) These 
phototoxic chemicals have evolved in plants as a host defense mechanism against plant 
pathogens and herbivores (2). In plants, in addition to self-defense, these chemicals are 
also involved in stress response pathways and hormonal regulation (2). It has been found 
that these chemicals can act as alleochemical compounds, which inhibit seed germination 
and control growth under unfavorable environmental conditions (2). The phototoxicty of 
these compounds has not only been beneficial for plants, but has also been useful for 
humans since the ancient times. The therapeutic effects of these compounds combined 
with sunlight have been known for thousands of years treating various skin diseases. The 
most common furocoumarin, psoralen has been used in Egypt and India since 1200-2000 
BC to treat skin disfiguring diseases such as vitiligo and leukoderma (1). 
 The modern medical applications of psoralen began with the isolation of the 
crystalline structure of 8-methoxypsoralen from the plant Ammi majaus in 1940s in Egypt 
(1). 8-methoxypsoralen combined with sunlight was first used in late 1940s to treat 
vitiligo (1, 3). Subsequently, it was found that artificial long wavelength ultraviolet light 
(UV-A, 320-400nm) activated 8-methoxypsoralen and inhibited epidermal DNA 
synthesis (1, 3, 4). Although, the phototoxic effect of psoralen was known since early 
1950s, the photochemotherapy or PUVA (psoralen+UVA), as it came to be known, was 
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developed and extended to the treatment of psoriasis only in the early 1970s (1, 3-6). In 
recent years, PUVA therapy has been applied to the treatment of other medical conditions 
including cutaneous T cell lymphoma, prostate cancer, and stenosis (7-10).   
Psoralen and DNA Interstrand Crosslink Formation 
 Psoralen, the most commonly found furocoumarin, is a tricyclic linear aromatic 
compound that contains a furan ring and a pyrone ring at each end of the molecule and 
(Figure 1-1) (11). Psoralen DNA interstrand crosslinks are asymmetrical and contain 
cycloaddition products of the pyrimidines on the furan and pyrone sides of the molecule. 
While psoralen does not exhibit sequence specificity for DNA binding, it preferentially 
forms covalent bonds with thymine. In the absence of ultraviolet light, psoralen 
intercalates between base pairs of the DNA helix and forms hydrogen bonds with 
pyrimidines. Upon exposure to the ultraviolet light (>320nm), photoaddition occurs 
between the C5=C6 double bond of the pyrimidine and the C4’=C5’bond of the furan or 
C3’=C4’ of the pyrone (Figure 1-2) (11-13). After the first photoaddition, furan side 
monoadducts can absorb a second photon and become converted to a crosslink by 
cycloaddition between the pyrone double bond and a thymine on the opposite strand 
(Figure 1-2) (12-14). In contrast, nonlinear psoralen derivatives such as angelicin are only 
able to form monoadducts due to their angular structure (Figure 1-1) (15, 16). Thus, 
although angelicin is similar to psoralen in structure, it usually requires higher doses to 
have similar therapeutic effects (15, 16).  
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 Interstrand crosslinks covalently binds to two DNA strands preventing DNA 
strand separation, and represent an absolute block to processes such as DNA replication 
and transcription. The mutagenic and cytotoxic nature of photoadducted 8-
methoxypsoralen was demonstrated in the 1950s and these crosslinking agents remain 
among the most genotoxic compounds in use today (1, 6, 8, 9).  
Repair of the DNA interstrand crosslinks  
DNA interstrand crosslinks involve both strands of the duplex DNA and present a 
unique challenge for the cell to repair. Incisions on both strands of the DNA fragment to 
remove the crosslink would result in a loss of genetic information, but if the damage is 
unrepaired, would result lethality. Current models of the interstrand crosslink repair have 
proposed that multiple repair pathways are likely to be involved (17-21). However, 
whether and how these multiple repair pathways process these lesions is poorly 
understood and remains to be characterized. Therefore, in the next chapters I describe 
experiments designed to test aspects of two predominant models.  
In both models, the first step of the interstrand crosslink repair involves 
nucleotide excision repair with subsequent steps performed either by recombination or 
translesion DNA synthesis pathways (17-22). The individual repair pathways and how 
they fit in the context of present models are described in the following sections.  
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Figure 1-1: Structure of furocoumarins  
Furocoumains are tricyclic compounds containing furan and pyron rings.  
Linear forms of furocoumarins include psoralen and its derivatives. 
Angelicin is an example of an angular furocoumarins.  
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Figure1-2: Formation of DNA crosslinks in thymine (Asymmetrical lesion). 
Absorption of first photon covalently binds psoralen to the thymine in one strand and 
creates a monoadduct. Absorption of the second photon can convert monoadducts in to 
the crosslink by cycloaddition to the adjacent thymine. Adapted from (17)  
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Nucleotide Excision Repair 
Nucleotide excision repair (NER) is the primary repair pathways in Escherichia 
coli for repairing bulky DNA lesions (23-26). NER is highly conserved from bacteria to 
mammals and recognizes a wide range of chemically distinct lesions (Reviewed in (27-
29)). Removal occurs through a process of dual incisions in the lesion containing strand 
followed by a resynthesis step using the complementary strand as a template. UvrA is 
involved in the initial recognition of lesions in DNA(28). The protein is part of the ATP 
binding cassettes superfamily of ATPases that act as molecular matchmakers to affect 
several cellular processes, including DNA repair (30, 31). UvrA dimers form a groove 
that interacts with duplex DNA. Damage containing DNA distorts the helical backbone 
and causes a conformational change in the UvrA dimer, which in turn increases its DNA 
binding affinity (30, 32). UvrA2 binding to distorted DNA is transient and requires 
association with UvrB(31, 33).  The (UvrA) 2UvrB complex associates stably with lesion 
containing DNA and recruits the third protein UvrC (31). UvrC possess two catalytic 
domains responsible for the 5’and 3’ incisions of the damage containing DNA (34).  The 
N-terminus of UvrC contains the 3’ endonuclease that makes its incision at the fourth or 
fifth phosphodiester bond 3’ from the lesion (34-37).  The 3’ incision is thought to 
precede the 5’ incision, which is catalyzed by the C-terminal domain and occurs at the 
eighth phosphodiester bond 5’ from the lesion (34-37). The C-terminal domain also 
contains a helix hairpin helix motif that is essential for this reaction and shares 33% 
sequence homology with human ERCC1. ERCC1 together with XPF catalyze the 5’ 
incision reaction during human nucleotide excision repair (38, 39). Following dual 
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incisions of the lesion containing fragment, UvrD helicase unwinds the damaged DNA 
and displaces the (UvrA) 2UvrB UvrC complex. The gap that is left is filled in by DNA 
polymerase I using the complementary strand as the template and is sealed by DNA 
ligase (40, 41). 
 In addition, E coli also encodes a second endonuclease called Cho (UvrC 
homolog) that is functions with the nucleotide excision repair pathway and is upregulated 
along with uvrA and uvrB in response to DNA damage as part of the SOS response (42, 
43) . Notably uvrC is not upregulated by the SOS response (43). Cho shows homology 
with the N- terminus of the UvrC and in vitro, catalyzes the 3’ incision reaction at the 
eighth or ninth phosphodiester bond 3’ to the lesion, four nucleotides downstream from 
where UvrC incises DNA(35, 36, 42). Similar to UvrC, Cho also requires UvrAB for its 
nuclease activity and is recruited to the DNA by UvrB; however, Cho binds to the UvrB 
at a different domain than UvrC (42). It is unclear why only a subset of bacteria encodes 
both UvrC and Cho or even what the function of Cho might be in these species and its 
role in vivo remains undefined (43). Several in vitro studies have suggested that Cho 
might make incisions at bulky lesions when UvrC is unable make the appropriate 
contacts with DNA (42). In support of this, bulky lesions such as cholesterol and menthol 
have been shown to be more efficiently incised by Cho than UvrC in vitro. However, 
whether Cho plays such a role in cells is unknown. In chapter II, I examine the 
contribution of Cho and the various nucleotide excision repair proteins to survival and 
repair of psoralen-induced lesions.  
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Recombinational Repair  
Homologous recombination is the main pathway by which cells repair double-
strand DNA breaks and daughter strand gaps in E coli (44-46). The primary protein of the 
homologous recombination is RecA, which binds single stranded DNA and initiates 
strand exchange with homologous duplex DNA in vitro.(47-49) RecA loading onto single 
stranded DNA is facilitated by one of two pathways, RecBCD or RecF(44, 50-52). 
RecBCD is a helicase/nuclease that unwinds and preferentially degrades the 5’ ends of 
DNA at double-strand DNA ends to generate 3’ single strand overhanging DNA 
molecules which serve as substrates for RecA loading(49, 50, 52-54). Alternatively, 
RecF, RecO, and RecR, are thought to act primarily at single strand gaps and single to 
double strand DNA junctions and operate to recruit RecA loading at these sites (46, 50, 
52, 55-57).  
Translesion synthesis 
 Translesion synthesis is an alternative to repair and allows replication to occur on 
templates containing lesions that have not been repaired (18, 58-60). In vitro, translesion 
DNA polymerases are able to incorporate nucleotides opposite to DNA lesions at higher 
efficiency than the replicative polymerase (DNA polymerase III) (61-66). While cell 
survival after DNA damage increases as a result of translesion synthesis, it is often 
associated with mutagenesis (58, 61, 63, 65, 67, 68).  
E coli encode three translesion DNA polymerases, Pol II (polB), Pol IV (dinB) 
and Pol V (umuD and umuC) (61, 69) . Pol IV and PolV are Y family polymerases, while 
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Pol II polymerase is a B family polymerase (61, 69). These DNA polymerases are 
damage inducible and their expression is upregulated as a part of the SOS response (64, 
68). In vitro, the E coli translesion DNA polymerases show specificity for the type of 
DNA lesion they are able to bypass as well as sequence context variation in each activity 
(58, 61, 62, 70). For example, Pol V, but not Pol II or Pol IV increases cell survival 
following UV irradiation, while Pol IV contribute to viability after nitrofurazone 
treatment (60, 70).  
Fanconi anemia pathway and DNA interstrand crosslink repair in mammals 
 In mammalian cells, Fanconi anemia pathway is the main DNA interstrand 
crosslink repair pathway during S phase (71-73). Fanconi anemia is a rare recessive 
disease that is characterized by hypersensitivity to interstrand crosslinks(71). Patients 
having mutations in Fanconi anemia genes are highly susceptible to cancer, present with 
bone marrow failure, growth retardation, hyperpigmentation, and kidney 
malfunction(71). Fanconi anemia includes more than 15 complementation groups and 
genes that can be divided into three main functional groups. Eight proteins FANCA, 
FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM and two associated 
proteins , FAAP24 and FAAP100 form the core complex, which functions as a ubiquitin 
E3 ligase which mono-ubiquitinates the second functional complex, FANCD2/FANCI, 
known as ID complex(71, 74) . Ubiquination of ID initiates the repair process following 
replication blockage by DNA interstrand crosslinks (71, 74). A third functional group 
consisting of FANCD1, FANCJ and FANCN(75). FANCM/FAAP24 within the core 
complex are thought to act as molecular sensors to detect replication fork blockage (76). 
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Detection of replication fork arrest leads to FA core complex formation and 
ubiquitination of subsequent complexes, which is required to recruit downstream proteins 
for repair proteins (71, 73, 74). The Fanconi anemia pathway is thought to recruit several 
endo- and exo-nucleases from other repair pathways to initiate the incision of crosslinks 
(72). However, it still remains unclear how these various proteins collaborate with each 
other to complete the repair process and their exact role in the FA pathway are not 
known. One of the main endonucleases recruited during replication fork blockage is 
XPF-ERCC1 endonuclease (77). This endonuclease is responsible for making the 5’ 
within the NER pathway. However, XPG, the 3’ endonuclease is not recruited by FA 
pathway (78-82).  In addition, two other endonucleases are also thought to be involved in 
the later stages of the FA pathway, FAN1- a structural dependent endonuclease having 5’ 
endonuclease activity and weak 5’ to 3’ exonuclease activity (83-85) , and Mus81-Eme1- 
a structure-dependent 3’ flap endonuclease associated with mismatch repair (86) .   
The FA pathway is speculated to be specific for repairing lesions encountered 
during replication, and most models suggest that distinct mechanism may exist to repair 
crosslinks independent from replication (71-73). Similar to mammalian cells, prokaryotes 
may have a unique pathway designated to repair lesions that block DNA replication. I 
discuss this in relation to Cho function in in E chapter II of my thesis.  
Models of DNA Interstrand Crosslinks 
 Two models for prokaryotic interstrand crosslink repair involve nucleotide 
excision repair coupled with either recombinational (Figure 1-3A) or translesion 
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synthesis (Figure 1-3B) (17). 
 Cole first proposed the nucleotide excision repair-homologous recombination 
model of interstrand crosslink repair (Figure 1.3A) based on survival assays of uvrA and 
recA mutants in E coli. Using psoralen interstrand crosslinks as his model lesion, Cole 
found that wild type cells were able to survive up to 65 lesions in their genomes (20, 21). 
In contrast, mutants in either uvrA or recA were able to survive 16 and 7 genomic lesions, 
respectively, while uvrA recA mutant was able to tolerate less than one interstrand 
crosslink per genome. According to the model, UvrABC first makes dual incisions on the 
strand bearing the furan side adduct, leaving the oligonucleotide containing the crosslink 
covalently bound to its complementary strand. This intermediate is then proposed to 
serve as a substrate for RecA- mediated strand exchange. However, in vitro studies have 
demonstrated, that if true, it is likely to require significant exonucleolytic processing 
before RecA can recognize and initiate strand exchange (22, 87-89). The resulting three 
stranded structure is then proposed to a substrate for a second round of incisions by 
UvrABC to remove the remaining pyrone side adduct, leaving a single strand gapped 
molecule that is filled and sealed by DNA Pol I and DNA ligase activities (22, 87-90). 
 An alternative model was proposed to account for the possibility that no 
homologous DNA sequence is present, such as in cells that have just divided or are in 
stationary phase (18, 19, 91). In this model, translesion synthesis substitutes for 
recombination to provide a template prior to the second round of incisions, however the 
remaining steps remain similar (Figure 1.3B) (87, 89). In vitro, DNA Pol II or Pol IV 
have been shown to be capable of bypassing different forms of DNA crosslinks (18, 19, 
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91). 
It is important to note that the proteins proposed in these models are based 
primarily on the in vitro hypersensitive of mutants and the in vitro reconstitution of 
partial reaction steps. However, no intermediates have been observed in vivo to support 
these models Therefore, the overall goal of this thesis is to characterize the proteins and 
cellular pathways involved in the repair and survival of psoralen plus UVA-induced 
damage in E coli. Chapter II describes experiments that determine which nucleotide 
excision repair proteins contribute to the removal of psoralen DNA interstrand crosslinks 
in vivo. In chapter III, I address the contribution of recombination proteins and 
translesion DNA polymerases to cellular survival following psoralen-UVA treatment.  
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Figure 1-3: Models of Interstrand Crosslink Repair. A) Recombination dependent 
DNA interstrand crosslink repair. B) Translesion polymerases dependent interstrand 
crosslink repair.  Adapted from. (17) 
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CHAPTER II 
Cho IS SPECIFICALLY REQUIRED FOR THE REPAIR OF DNA INTERSTRAND 
CROSSLINKS 
ABSTRACT 
DNA interstrand crosslinks are complex lesions that covalently bind to both strands of 
the duplex DNA. The repair of interstrand crosslinks is proposed to be initiated by the 
NER repair pathway.  In this study, we characterized the role of NER pathway in the 
presence of psoralen-induced lesions, which forms both interstrand crosslinks and 
monoadducts. Unexpectedly, we observed that the nucleotide excision repair mutants 
exhibit differential sensitivity to psoralen-induced damage, with uvrC mutants being less 
sensitive than either uvrA or uvrB. Furthermore, we found that Cho, an alternative 
endonuclease, is responsible for the reduced hypsersensitivity of uvrC mutants, and is 
required specifically in the presence of DNA interstrand crosslinks.Three models are 
discussed for the mechanism by which Cho may be acting in this pathway. 
INTRODUCTION 
Psoralens are tricyclic asymmetrical compounds containing furan and pyron rings, 
and bind DNA nonspecifically with a preference for pyrimidines forming noncovalent 
bonds(17, 18). Upon absorption of UV-A light, a covalent bond forms through 
photoaddition between the C5=C6 double bond of the pyrimidine and the psoralen’s 
C4’=C5’ bond of the furan or C3’=C4’ of the pyrone moiety (17, 18, 44) . Absorption of 
a second photon results in photo addition on the remaining furan or pyrone with a second 
pyrimidine, creating a DNA interstrand crosslink (17, 18, 23). Thus, psoralen-induced 
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damage consists of both monoadducts and DNA interstrand crosslinks. Interstrand 
crosslinks covalently bind both strands of the duplex DNA, thereby inhibiting any 
cellular process that requires strand denaturation, such as transcription and replication. 
This inhibition is generally considered to be the reason for the potency of their toxicity, 
and use in treating different skin diseases such as vitiligo, psoriasis, and as a 
chemotherapeutic for some forms of cancer (16, 22, 32, 36, 37).  
Several models have been proposed as to how DNA interstrand crosslinks are 
repaired, although many aspects of these models still remain unknown. A feature 
common to all these models is that the repair process is initiated by nucleotide excision 
repair, followed by the sequential action of other DNA repair processes, such as 
recombination or translesion synthesis (2, 7, 15). 
 Nucleotide excision repair pathway is the primary pathway for repairing bulky 
DNA lesions in cells (39, 45, 46). In Escherichia coli the incision complex for this 
pathway is made up of UvrA, UvrB and UvrC(45).  UvrA forms a homodimer that has a 
high affinity for damaged DNA relative to non-damaged DNA (34, 39, 45). In a presence 
of a distorting lesion, a complex consisting of UvrA2B specifically binds to the strand 
containing the lesion (34, 35). Binding of the UvrA2B complex recruits the UvrC 
endonuclease, which makes an initial incision located on the fourth or fifth 
phosphodiester bond 3’ to the lesion, immediately followed by a second incision at eighth 
phosphodiester bond on 5’ side (29, 40, 50).  After the incision step, the UvrD helicase 
displaces the UvrA2BC complex and along with the 12-13 bp segment containing the 
lesion before DNA polymerase I and ligase re-synthesize and seal this segment using the 
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undamaged strand as a template (47).  
Several studies support the idea that NER is involved in the repair of interstrand 
crosslinks (4-7). In vivo, mutants defective in any one of the nucleotide excision repair 
genes are hypersensitive to crosslinking agents (6, 7). Furthermore, all three NER 
mutants are defective in their ability to incise DNA containing interstrand crosslinks in 
vivo, as measured in alkaline CsCl gradients (6, 7) . In vitro, UvrA UvrB and UvrC are 
capable of incising oligonucleotides or plasmids containing a psoralen-induced 
interstrand crosslink, with dual incisions occurring predominantly on the strand 
containing the furan moiety (40, 42, 43, 49).   
Based on these observations, and other lesions known to be repaired by nucleotide 
excision repair, it was inferred that all three subunits of the repair complex were required 
and contributed equally to the crosslink repair. However, a recent study reported that 
uvrB mutants were more sensitive to psoralen-induced damage than either uvrA or uvrC, 
suggesting a potentially unique mechanism of repair for these lesions (26) . While this 
represents a potentially important observation, they also appeared to contradict a number 
of earlier studies that suggested uvrA and uvrB mutants are equally sensitive to psoralen 
treatment (3, 13) . 
Thus to characterize the comparative roles of the NER proteins in the processing 
and repairing of DNA interstrand crosslinks, we constructed isogenic mutant strains 
lacking each of the nucleotide excision genes and characterized their ability to survive 
and incise psoralen-induced DNA damage. In do so, we observed that a mutant of the 
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nuclease subunit, UvrC, was less sensitive to psoralen-induced damage.We found that an 
alternative nuclease, Cho, could account for the reduced hypersensitivity, and that Cho 
function appears to be specific for the repair of interstrand crosslinks. 
MATERIALS AND METHODS 
Bacterial Strains 
The parental strain used in this study was SR108, a thyA36 deoC2 derivative of 
W3110. Isogenic strains lacking uvrA (HL952), uvrC (HL925), and uvrD (CL1302), were 
constructed by standard P1 transduction and have been reported previously (19, 20, 33) . 
The cho gene was replaced from codons 4 to 280 with cat, conferring chloramphenicol 
resistance, using PCR replacement with the primers,     
5'-ggatagataaccagcattcggagtcaacagtggtacggcgatgagacgttgatcggcac-3’                                
 and  
5'-ctcgctggtcattcgccggatcaagttcagtaatttcatactttcgaatttctgccattc -3’, 
followed by recombineering into DY329 to generate CL904(19) .The uvrB gene was 
replaced from codons 1 to 672 with cat using PCR replacement with the primers,                                                                                                    
5’-attacatacctgcccgcccaactccttcaggtagcgactcatgagacgttgatcggcac-3’   
and                                   
 5’-ggctgttttccgtttgtcatcagtcttcttcgctatcctgctttcgaatttctgccattc-3’,                                      
 followed by recombineering into DY329 to generate CL1673(53). CL908 (SR108 
cho::cat) and CL1735 (SR108 uvrB::cat) were constructed by P1 transduction of cho::cat 
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and uvrB::cat from CL904 and CL1673, respectively, into SR108. CL2155 (SR108 
cho::cat uvrC297::Tn10) was generated by P1 transduction of the uvrC297::Tn10 allele 
from HL925 into CL908. 
 
 The parental strain, AB1157 (thr-1 leuB6 proA2 his-4 argE3 thi-1 lacY1 ara-14 
xyl-5 mtl-1 tsx-33 rpsL31 supE44 galK2) has been reported previously(14).AB1886 
(uvrA6), AB1885 (uvrB5), and AB2498 (uvrC34) are nitrous acid-mutagenized 
derivatives of AB1157 and have been previously reported HL759 (uvrA6 zjd::Tn5) has 
been reported previously (14) .The uvrB5 allele from AB1885 was linked to kanamycin 
resistance in two steps. First, the kanR gene was inserted 23 bp downstream from mngB 
using PCR insertion with the primers,   
5’-gttaccggcttgcctgaatagcaatcaaaccgaagccacatgtgacggaagatcacttcg-3’                                    
  and 
5’-atgaacaaagcgccctttgtcaacaatctggccgcgcataaccagcaatagacataagcg-3’,  
followed by recombineering into DY329 to generate CL2301. mngB::kan, from CL2301, 
was then transduced into AB1885 using standard P1 transduction to generate CL2337. 
The uvrB5 allele is ~50% cotransducible with mngB::kan. The uvrC34 allele from 
AB2498 was linked to kanamycin resistance in two steps. First, the kanR gene was 
inserted 106 bp upstream from torY using PCR insertion with the primers,                            
5'-ggatagataaccagcattcggagtcaacagtggtacggcgatgagacgttgatcggcac-3’                                    
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and 
 5'ctcgctggtcattcgccggatcaagttcagtaatttcatactttcgaatttctgccattc-3’  
followed by recombineering into DY329 to generate CL2280. torY::kan, from CL2280, 
was then transduced into AB2498 using standard P1 transduction methods to generate 
CL2341. The uvrC34 allele is ~60% co-transducible with torY::kan. CL2343 (SR108 
uvrB5 mngB::cat) and CL2472 (SR108 uvrC34 torY::cat) were constructed by P1 
transduction of uvrB5 mngB::cat and uvrC34 torY::cat from CL2337 and CL2341, 
respectively, into SR108. CL23 (SR108 uvrA6 zjd::Tn5) was constructed by P1 
transduction of uvrA6 zjd::Tn5 from HL759 into SR108. Transductants were verified by 
antibiotic sensitivity and sensitivity to UV irradiation at 254 nm where appropriate. 
Strains were transformed with plasmid pBR322 for interstrand crosslink incision 
experiments. 
Psoralen-UVA and Angelicin-UVA Survival Assays 
Overnight cultures grown in Davis medium supplemented with 0.4% glucose, 
0.2% Casamino Acids, and 10 μg/ml thymine (DGCthy). Fresh overnight cultures were 
diluted 1:100 in DGCthy medium and grown at 37°C to an optical density at 600 nm 
(OD600) of 0.3. At this time, 10 µg/ml of 8-methoxypsoralen or 20 g/ml of angelicin was 
added to the cultures and incubation continued for 5 min before irradiation with UV-A 
light. Cells were irradiated using two 32-watt UVA bulbs (Sylvania) with a peak 
emittance of (320 nm) at an incident dose of 6.9 J/m2/s. At the times indicated, 100-µL 
aliquots were removed from each culture and serially diluted in 10-fold increments. 
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Triplicate 10-l aliquots of each dilution were spotted onto Luria-Bertani agar plates 
supplemented with 10 g/ml thymine (LBthy) and incubated at 37°C. Viable colonies 
were counted the next day to determine the surviving fraction.  
8-methoxypsoralen was purchased from Acros Organics, item 298-81-7 lot 
A0143457. Angelicin was purchased from Sigma-Aldrich, item A0956 lot 042M4054V. 
Both the NMR spectra and an HPLC profile with/without psoralen spike revealed no 
detectable contamination of other prosalen deriviaties in the angelicin preparation, 
UVC Survival Assay 
 Fresh overnight cultures were diluted 1:100 in DGCthy medium and grown at 
37°C to an OD600 of 0.4. Ten-l aliquots of serial 10-fold dilutions were plated in 
triplicate onto LBthy agar plates and UVC-irradiated at the indicated doses. UVC 
irradiation used a 15-watt germicidal lamp (254 nm) at an incident dose of 0.9 J/m2/s. 
Plates were incubated at 37°C and colonies were counted the next day to determine the 
surviving fraction. 
In vitro Plasmid Crosslinking Assay 
Purified plasmid was treated with 10µg/mL of 8-methoxy-psoralen or 20µg/mL of 
angelicin and irradiated with increasing doses of UV-A light (320 nm). Treated plasmid 
DNA was digested with PuvII (Fermentas) over night at 37C. Samples were 
electrophoresed on a 0.5% alkaline agarose gel (30mM NaOH and 1mM EDTA) at 30 V 
for 16 h. DNA in the gels was then transferred to Hybond N+ nylon membranes (GE 
Healthcare) using standard Southern blotting techniques. The plasmid DNA was detected 
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by probing with 32P-labeled pBR322 that was prepared by nick translation (Roche) using 
alpha32P-dCTP >6000Ci/mmol (Perkin-Elmer) and visualized using a Storm 840 
phosphorimager (GE Biosciences) and its associated ImageQuant analysis software.   
In vivo Interstrand Crosslink Incision Assay 
Cultures containing the plasmid pBR322 were grown overnight at 37°C in 
DGCthy medium supplemented with 100 µg/ml of ampicillin. A 0.2-ml aliquot from this 
culture was pelleted and resuspended in 20-ml DGCthy medium without ampicillin and 
grown in a 37°C shaking water bath to an OD600 of 0.4. At this time, cultures were 
exposed to 10 µg/ml 8-methoxypsoralen for 5 min at 37°C and subsequently irradiated 
with 6.2 kJ/m2 UV-A light (320nm). The cells were then filtered and collected on 
Millipore 0.45-µm general filtration membranes, resuspended in fresh, prewarmed 
DGCthy medium and allowed to recover at 37°C. At the times indicated, 0.75-mL 
aliquots of culture were transferred to an equal volume of ice-cold NET (100 mM NaCl, 
10mM Tris [pH 8.0], 20 mM EDTA [pH 8.0]), centrifuged for 2 min, resuspended in 140 
µl lysis buffer (1 mg/ml lysozyme, 0.5 mg/ml RNaseA in 10 mM Tris, 1 mM EDTA [pH 
8.0]), and incubated at 37°C for 30 min. Ten µl of 10 mg/ml proteinase K and 10 µl of 
20% Sarkosyl were then added to the samples, and incubation continued for a further 30 
min. Samples were then extracted with four volumes of phenol-chloroform , followed by 
four volumes of chloroform and then dialyzed against 200 ml of 1mM Tris (pH 8.0), 
2mM EDTA (pH 8.0) for 45 min using 47-mm Millipore 0.025-µm pore disks and 
digested with PvuII (Fermentas) overnight at 37°C. Samples were then electrophoresed 
on a 0.5% alkaline agarose gel (30mM NaOH and 1mM EDTA) at 30 V for 16 h. DNA in 
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the gels was then transferred to Hybond N+ nylon membranes (GE Healthcare) using 
standard Southern blotting techniques. The plasmid DNA was detected by probing by 
32P-labeled pBR322 that was prepared using nick translation (Roche) using alpha32P-
dCTP >6000Ci/mmol (Perkin-Elmer) and visualized using a Storm 840 phosphorimager 
(GE Biosciences) and its associated ImageQuant analysis software.   
The fraction of psoralen crosslinks formed at each time point was calculated as 
the ratio of DNA running above the linear band to the total DNA loaded, and normalized 
to the average of the fraction of crosslinks in untreated and preirradiated samples. 
Fraction of Crosslink                                                                    
 = (XDtimex/TDtimex)-(1/2(XDuntreated+XDpreirrdation)/TDuntreated+TDpreirradiation)) where XD 
represents crosslinked DNA and TD represents total DNA.  
RESULTS 
Irradiation with UV-C generates two predominant lesions, the cis, syn 
cyclobutane pyrimidine dimer and the pyrimidine 6-4-pyrimidine photoproducts in the 
DNA(27, 28).Repair of these lesions in E coli is known to require uvrA, uvrB and uvrC 
genes to initiate nucleotide excision repair of UV- induced DNA lesions (39). Mutants 
lacking any of these gene products fail to remove these lesions and are equally sensitive 
to UV-C irradiation (27). Consistent with earlier studies, we observed that the survival of 
our uvrA, uvrB and uvrC deletion mutants decreased at the same rate as the UV-C dose 
was increased, indicating that each protein contributes equally to survival following UV-
C-induced damage Figure 2-1A .  
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 We next examined the survival of these strains following psoralen-induced DNA 
damage. To this end, 10μg/ml 8-methoxypsoralen was added to growing cultures of the 
parental and mutant strains before they were exposed to 6.9/J/m2/s UV-A irradiation for 
increasing time periods .The fraction of cells surviving to form colonies was then 
determined.  
 In contrast to that observed in UV-C irradiation, the uvr strains did not equally 
contribute to survival of psoralen-induced lesions (Figure 2-1B). Relative to wild type 
cells, uvrA and uvrB mutants were equally hypersensitive to psoralen-induced damage. 
However, the hypersensitivity of uvrC mutants was significantly less than either uvrA or 
uvrB and required approximately twice as much UV-A radiation to reduce the survival of 
uvrC mutants to the level observed in uvrA or uvrB mutants. Importantly, no loss of 
viability was observed in wild type or uvrA cultures that were treated either with UV-A 
irradiation alone (Figure 2-1C) or incubated with psoralen alone, indicating that the 
hypersensitivity and loss of viability in these cells was specifically due to the 
photoactivated forms of psoralen and not due to the intercalation of psoralen or UVA-
specific damage . Thus, we observed that the uvrC gene is less sensitive to psoralen-
induced damage than either uvrA or uvrB.  
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Figure 2-1 In contrast to UV-induced damage, uvrC mutants are less sensitive to 
psoralen-induced adducts than either uvrA or uvrB mutants. 
The survival of cells following irriadiation with UVC light (254nm) (A) or UV-A light 
(340nm) in the presence of 10μg/ml 8-methoxy-psoralen (B) is plotted. The survival of 
cells following irradiation with UV-A light (340nm) in the absence of psoralen (C) is 
plotted. WT (open circles), uvrA (closed circles), uvrB (closed square), and uvrC (closed 
triangles).Graphs represent the average of three independent experiments. Error bars 
represent one standard deviation. 
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 These results were unexpected and contrasted with those of Lage et.al. (2010) in 
which they observed that uvrB was markedly more hypersensitive to psoralen-induced 
damage than either uvrA or uvrC (26). One potential reason for the discrepancy between 
our results and those of Lage et al are the differences between our experimental 
conditions. Lage et al (2010) used psoralen at concentrations of 0.1μg/ml, and then 
irradiated cultures for time periods extending up to several hours on ice to achieve lethal 
levels of psoralen-induced damage. Since the initial goal of our study was to observe the 
time course of psoralen crosslink repair in living cells, the temperature changes and long 
exposure times were impractical. Thus we treated our strain cultures with a higher 
concentration of 8-methoxypsoralen (10µg/ml) similar to other studies. Allowing us to 
reduce our irradiation times and avoid temperature changes. A second potential reason 
for the differences seen in our results and those of Lage et al 2010, could be due to the 
difference in strain backgrounds or the specific uvr alleles used in each study. The uvr 
mutants used in the Lage et al study were direct isolates from nitrous acid-mutagenized 
cultures(20). Previous studies have also reported that various strains of E.coli can vary 
significantly in the sensitivity to DNA crosslinks (4, 20).  
In order to test and differentiate between the possibilities, we repeated the 
survival assays using the strains from the Lage et al study with high 8-methoxypsoralen 
concentrations (10µg/ml) and short UV-A exposure times. As shown in Figure 2-2A, we 
were able to reproduce their observations, demonstrating the extreme sensitivity of strain 
AB1885, containing the uvrB5 mutation, to psoralen-induced damage. The results refute 
the idea that underlying differences between our results are due to different treatment 
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conditions and suggest that uvrB5 allele or strain background may be the reason for its 
extreme hypersensitivity.  To test this hypothesis, we moved the uvrA6, uvrB5, and 
uvrC34 alleles in the SR108 background using standard P1 transduction to generate 
isogenic strains. We then repeated the experiments as before. As shown in Figure 2-2B, 
after moving alleles into isogenic backgrounds, hypersensitivity of the uvrB5 mutant was 
similar of that uvrA6 allele. These results indicate that extreme hypersensitivity of the 
strain AB1185 is likely due to secondary mutations or differences between the various 
backgrounds. However, consistent with the initial observation in Figure 1B, the 
hypersensitivity of uvrC34 mutant was more modest than that of either uvrA or uvrB in 
all strains examined, arguing that the loss of uvrC is not as lethal as the loss of uvrA or 
uvrB when psoralen-induced damage is present in the cell.  
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Figure 2-2 Isogenic backgrounds are important when comparing sensitivities of the 
NER mutants to psoralen  
A) The survival of uvrA6, uvrB5 and uvrC34 mutants following irradiation UV-A 
(340nm) light in the presence of 10μg/ml 8-methoxy-psoralen is plotted before (A) and 
after (B) moving the alleles into isogenic backgrounds. (A) AB1157 wild type strain, 
uvrA6 in strain AB1886 (closed blue circles), uvrB5 in strain AB1885 (blue square), 
uvrC34 in strain AB1884 (B) SR108 parental (open blue circles), uvrA6 in SR108 (closed 
black circles), uvrB5 in SR108 (black square closed), uvrC34 in SR108 (closed triangles) 
Graphs represent the average of three independent experiments. Error bars represent one 
standard deviation. 
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 Although the UvrABC excision is thought to function as a complex (40, 41), the 
survival assays indicated that uvrC was less sensitive to psoralen-induced damage than 
uvrA or uvrB.  Given that UvrA and UvrB act in the initial recognition step of the NER 
pathway, while uvrC functions as the nuclease, I hypothesized that an alternative 
endonuclease might be participating in the repair of the psoralen-induced damage. Cho 
(UvrC homolog), was identified as a putative nuclease that is upregulated following 
DNA damage (30) . Subsequent biochemical studies showed that in the presence of the 
UvrABC endonuclease, Cho was able to make a 3’ incision two bases further away than 
UvrC and that this activity could act on a variety of lesions in vitro. However, its  
function in vivo remains unclear as cho mutants are not sensitive to UV or other forms of 
damage that have been examined (30).To test whether Cho was responsible for the 
increased resistance of uvrC to psoralen-induced damage, we characterized cho mutants 
and cho uvrC double mutants for their ability to survive psoralen-induced damage. As 
shown in Figure 3A, cho mutants were only modestly sensitive to the psoralen-induced 
damage, relative to other uvr mutants (Figure 2-3A). Interestingly however, the absence 
of Cho increased the hypersensitivity of uvrC mutants to a level that was similar to uvrA 
and uvrB mutants (Figure 2-3A). The observation indicates that Cho is responsible for the 
decreased sensitivity of uvrC mutants in the presence of psoralen-induced lesions. 
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Figure 2-3 Cho accounts for the reduced sensitivity of uvrC mutants and is required 
specifically in the presence of interstrand DNA crosslinks. A) The survival of cells 
following irradiation with increasing doses of UV-A (340nm) light in the presence of 
10μg/ml 8-methoxy-psoralen (A) or B) 20μg/ml of angelicin is plotted. WT (open 
circles), uvrA (closed circles), uvrB (closed square), uvrC (closed triangles), cho (open 
diamonds), and uvrC cho (Open triangles)  
Graphs represent the average of the three or more independent experiments. Error bars 
represent one standard deviation. 
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8-methoxypsoralen is capable of creating both monoadducts and interstrand 
crosslinks with exposure to the UV-A light (1, 23) . One possible explanation for the 
increased sensitivity of Cho in the absence of uvrC is that Cho is required to act with 
UvrC on only one of these two classes of lesions. To test this idea, the experiments were 
repeated using angelicin in place of the 8-methoxypsoralen. Angelicin shares a similar 
structure to that of 8-methoxypsoralen, but is thought to only be capable of forming mono 
adducts due to its angular structure. In contrast to 8-methoxypsoralen, in the presence of 
angelicin, the relative hypersensitivity of the uvrC mutant increased to a level that 
approached that of the uvrA and uvrB mutants (Figure 2-3B). The slight resistance that 
remained between uvrC and the uvrA and uvrB mutant survival is likely to be due a low 
level of interstrand DNA crosslinks that still form in the angelicin-treated samples 
(Figure 2-4B). Although angelicin is reported to only be capable of forming 
monoadducts, we observed that our angelicin-treated DNA could form interstrand DNA 
crosslinks, although at a rate that was orders of magnitude less efficient than that of 8-
methoxypsoralen (Compare Figure 2-4 A and B).  
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Figure 2-4 Purified plasmid treated with angelicin UV-A light forms minor product 
of DNA interstrand crosslinks.  
A) Purified plasmid pBR322, was treated with 10μg/mL 8-methoxy-psoralen or B) 
20µg/mL angelicin and irradiated with UV-A (340nm) light for increasing doses. DNA 
was restricted with PvuII and analyzed by southern analysis following alkali-agarose gel 
electrophoresis using pBR322 as a probe to determine the amount of DNA interstrand 
crosslinks present.  
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Figure 2-5 UvrC but not Cho is required for the initial incision of the crosslink in 
vivo. 
A) Cultures containing the plasmid, pBR322, were irradiated with UV-A (340nm) light for 15 
min in the presence of 10μg/ml 8-methoxy-psoralen and allowed to recover. At the indicated time 
points, total genomic DNA was purified, restricted with PvuII, and analyzed by southern analysis 
following alkali-agarose gel electrophoresis using pBR322 as a probe to determine the amount of 
DNA interstrand crosslinks present in the plasmid DNA over the recovery period. A 
representative gel for WT uvrA, uvrB, uvrC, cho, and uvrC cho is shown. 
 B) The relative amount of crosslinks remaining in the plasmid DNA over time is plotted, as 
normalized to the amount of noncrosslinked plasmid DNA. Band intensities for the DNA 
crosslinked and uncrosslinked fragments at each time point were Quantified using imageQuant 
software. Fraction of crosslinks at each time point were determined by calculating the ratio of the 
DNA crosslink band to linear plasmid. WT (open circles), uvrA (closed circles), uvrB (closed 
square), uvrC (closed triangles), cho (open diamonds), and uvrC cho (Open triangles).  Plots 
represent the average of two independent experiments. Error bars represent the standard error of 
the mean. 
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 Based on the survival assays, Cho appears to contribute to the repair of DNA 
interstrand crosslinks. To examine whether the absence of Cho affects the ability to 
initiate repair of the crosslinks in vivo, we compared each mutant’s ability to incise 
interstrand crosslinks. To this end, I treated cultures containing the plasmid pBR322 with 
8-methyoxypsoralen and UV-A light and then allowed them to recover over a period of 
time. At various time intervals, aliquots of the culture were taken, and the genomic and 
plasmid DNA was purified and restricted with PvuII which linearizes the plasmid. The 
DNA was then electrophoresed in a denaturing agarose gel and plasmid DNA was 
detected by southern analysis. Under denaturing conditions, DNA molecules that contain 
interstrand crosslinks are prevented from separating and can be detected due to their 
slower migration pattern relative to linear strands in alkali gels. In wild type cultures 
immediately following irradiation, approximately 3.2% of the plasmid DNA contained an 
interstrand DNA crosslink (Figure 2-4A and C). Over the 90 minute recovery period, the 
fraction of DNA migrating in the crosslink region of the gel decreased to approximately 
0.57%, which we interpret to reflect incision of the crosslinks over time. In cultures of 
uvrA, uvrB mutants, 5.9% and 6.0% of the plasmid molecules contained DNA interstrand 
crosslinks immediately after irradiation. However, in these cultures, the crosslinks 
remained throughout the recovery period and no decrease in the shifted DNA band was 
observed, indicating that these cultures are impaired in their ability to make the initial 
incision (Figure 2-4A and 2-4C).  When I examined cultures of uvrC, I observed that the 
crosslinks formed and persisted similar to that seen in uvrA and uvrB cultures (Figure 2-
4B and 2-4C).  Thus although the uvrC mutant is markedly less sensitive, by this assay, it 
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appears to be as defective in making the initial incision as either uvrA or uvrB mutants.  
In contrast, crosslinks were incised in cho mutants at a rate that was similar to wild type 
cultures, as indicated by the decrease in the intensity of the crossed link DNA band.  In 
the uvrC cho double mutant, the initial incision was impaired to a similar extent as in 
uvrC mutants. We interpret these results to suggest that although Cho contributes to 
survival in the presence of interstrand DNA crosslinks, it is not required for the initial 
incision the DNA interstrand crosslinks in vivo. 
DISCUSSION 
 In this chapter, I investigated the role of nucleotide excision repair proteins in 
repairing psoralen-induced DNA damage. I found that not all the NER subunits 
contribute equally to the survival of psoralen-induced damage. Notably, mutants lacking 
the endonucleotic subunit UvrC are less sensitive to psoralen-induced damage than 
mutants lacking the recognition proteins UvrA or UvrB. The increased resistance of uvrC 
was found to depend upon Cho, a secondary UvrABC-dependent endonuclease that is 
strongly induced after DNA damage (30). 
 The observation that Cho inactivation reduced the partially sensitive uvrC mutant 
to a level similar to that of uvrA and uvrB mutants, suggested that Cho is only required to 
participate in a subset of the psoralen-induced repair events. Since psoralen plus UV-A 
irradiation generates two classes or subsets of DNA lesions, one possibility is that Cho 
functions with UvrABC to repair psoralen interstrand crosslinks, but not monoadducts. 
Using a psoralen-derivative that predominantly forms monoadducts, I found that Cho was 
specifically required for survival in the presence of DNA interstrand crosslinks, but did 
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not contribute significantly to the repair of monoadducts. Interestingly, although Cho 
contributes to survival in the presence of crosslinks, its absence did not affect the cell’s 
ability to make the initial incision on plasmids in vitro, suggesting that Cho operates later  
in the repair process or in only a subset of crosslink repair events.    
 I consider three possible scenarios that Cho function is required in the cell for 
repairing DNA interstrand crosslinks. One possibility is that Cho is required for repair of 
the interstrand crosslinks that block replication is blocked or those occurring in the global 
genome overall (Figure 2-5). Several studies based upon experiments using mammalian 
cell extracts have proposed that the repair of interstrand DNA crosslinks can occur 
through replication dependent and replication independent pathways (25, 51, 52). 
Fanconi anemia is a rare inherited disease that predisposes humans to cancer, involving 
more than 15 complementation groups, which renders cells highly sensitive to DNA 
interstrand crosslinks. Recent studies have suggested that the Fanconi anemia defect is 
specifically related to the repair of crosslinks encountered by the replication fork (51). In 
addition, the Fanconi anemia proteins FANCD2 and SLX4/FANCP interact with the 3’ 
endonuclease of the mammalian nucleotide excision repair complex, XPF-ERCC1, to 
affect repair. The participation of XPF-ECRCC1 is independent from its role in 
nucleotide excision repair, as the remaining subunits of the NER complex are not 
required (51) (24). By analogy in E. coli, it is possible that the alternative nuclease, Cho, 
functions specifically at the replication fork to effect repair. In vitro, incision of DNA 
interstrand crosslinks occurs more efficiently on underwound superhelical substrates, 
perhaps suggesting that superhelicity differences between the DNA at replication forks 
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and the overall chromosome necessitate a role for Cho to act with UvrC in some cases 
(31). A role in replication-coupled repair would also be consistent with the observation 
that Cho has only a minor effect on the rate of crosslink incisions (Fig 2-5). Similar to the 
case with UV-induced damage, since the proportion of lesions requiring replication-
specific repair events is quite small, mutants defective in replication-coupled repair 
would be expected to appear repair proficient (10). However, other observations do not 
support such a role for Cho. Defects in replication-coupled repair typically have severe 
effects on cell survival in both prokaryotes and eukaryotes, even when only low levels of 
damage are present (8-11).Yet the absence of Cho, by itself, does not have a large effect 
on cell survival. 
 A second possible role for Cho is that it acts as a secondary nuclease for the 
nucleotide excision repair complex that increases the efficiency of incision for some 
forms of bulky adducts (Figure2- 6). In vitro, the incision of the interstrand crosslinks by 
the nucleotide excision repair complex is influenced by the sequence context with 
preferential incisions occurring when the strands are GC enriched 5’ and 3’ to the 
adducted bases (21, 38). The longer excision patch resulting from Cho incision may 
enhance incision at poorly recognized or bulky lesions that cause problems for the core 
UvrABC exinuclease complex. Such a function could be consistent with both the survival 
we observe. Cho, along with UvrA and UvrB, is upregulated following DNA damage 
(12). However, UvrC is the only subunit that is not upregulated by DNA damage. If Cho 
did function to increase the efficiency of excision of psoralen damage, it would be 
expected to have a more significant effect on survival when high levels of DNA damage 
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are present, and less of an effect at lower levels of damage, as seen in our survival data. 
However, one might still expect to see that the rate of incision is affected in the absence 
of Cho, and this did not appear to be the case (Figure 2-5). 
A third possibility is that Cho may function in a later step in the crosslink repair 
pathway, after the initial incision (Figure 2-7). In vitro, UvrABC exinuclease incises 
psoralen interstrand crosslinks on the strand containing the furan moiety of the psoralen 
molecule while leaving the strand containing the pyrone moiety intact (42, 43, 47-49). 
Replication independent repair models propose that following incision, either 
recombination or translesion synthesis generates a bulky three stranded structure, with the 
oligo containing the adduct. It is possible that Cho is required to make this second 
incision on the pyrone side strand, leading to the second round of repair. Cho protein is 
known to incise bulky substrates more efficiently than UvrC and Cho acting in this 
manner would be consistent with results showing that it remains proficient in making the 
initial incision (Fig 2-4) (30). An inability to carry out the second round of repair could 
also be less lethal than mutants unable to initiate repair, if alternative pathways, such as 
translesion synthesis or recombination, were able to compensate and act on the incised 
substrates when Cho is absent. Considering the angelicin survival data, and the psoralen 
in vivo incision results, I favor the third model as most likely the role of Cho in repairing 
DNA interstrand crosslinks. All our results are consistent with the model that Cho is 
required for the second incision step of the repair process, but not the first step. However, 
more experiments are required to confirm that Cho is responsible for the second incision 
of the repair process.  
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Figure 2-6: Model 1, Cho is required for repair of psoralen-induced lesions in a 
replication dependent manner.  A) Global repair pathway B) Cho protein is involved in 
repairing psoralen-induced lesions only at replication fork arrest and assist in making 
incision in addition to UvrC.  
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Figure 2-7: Model 2, Cho is required to increase the efficiency of psoralen-induced 
lesions in addition to UvrC. A) Main NER proteins repairing lesions. B) Cho is required 
to increase efficiency of incision rate in the presence of psoralen-induced lesions (bulkier 
lesions). 
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Figure 2-8: Model 3, Cho is responsible for the second incision step of the repair 
process at pyrone side of psoralen-induced lesions after recombination or 
translesion synthesis. Cho is responsible for the second incision followed recombination 
or translesion synthesis. In order for cells to completely remove the lesion, a second 
incision need to occur after first incision step. Cho makes the incision on pyrone side, 
while other main NER proteins are required to make the first incision on furan side.  
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CHAPTER III 
ELEMENTS OF RECOMBINATION PATHWAY AND TRANSLESION 
POLYMERASES ARE REQUIRED FOR THE REPAIR OF DNA INTERSTRAND 
CROSSLINKS 
ABSTRACT 
 Agents forming DNA interstrand crosslinks are highly toxic and widely used in the 
treatment of hyperplastic disease.  For these reasons the mechanism by which cells repair 
these lesions is of intense interest.  Most models propose that repair is initiated by the 
nucleotide excision repair pathway, and coupled with either recombination pathways, 
translesion synthesis pathways or both. However, following incision, these models 
remain highly speculative, and the role of recombination and translesion synthesis in the 
repair of interstrand crosslinks still remains unclear. In order to further characterize how 
recombination proteins and translesion synthesis polymerases contribute to the repair of 
interstrand DNA crosslinks, I examined how these gene products contribute to the 
survival of psoralen damage. I observed that both recBC and recF mutants were 
hypersensitive to psoralen-induced lesions; however neither mutant was as sensitive as a 
recA mutant. With respect to translesion synthesis, I found that Polymerase V was the 
only translesion polymerase that contributes to survival of psoralen damage. I discuss 
these results in relation to both prokaryotic and mammalian models for crosslink repair. 
INTRODUCTION   
 DNA interstrand crosslinks are a particularly lethal form of DNA damage that 
represents an absolute block to replication and transcription. A number of chemicals 
forming DNA crosslinks have proven to be highly toxic in nature, uniquely potent as a 
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chemotherapeutics, and highly effective in treating a range of diseases states involving 
hyperplastic or dysplastic conditions (1, 2). Psoralens are asymmetrical, tricyclic 
aromatic compounds, containing a pyrone and a furan ring (3-5). Psoralen intercalates 
into DNA and form monoadducts and interstrand DNA crosslinks upon absorption of one 
or two photons of UVA light, respectively (5). 
The mechanism of how cells repair DNA interstrand crosslinks has remained a 
challenging problem. It is widely accepted that repair involves proteins associated with 
the nucleotide excision repair pathway, since NER mutants in both bacteria and 
mammalian systems are hypersensitive to crosslinking agents (6-10) . Further, cellular 
studies, suggest that in the absence of these gene products, DNA interstrand crosslinks 
are not incised and persist in the DNA (6, 7).  However, nucleotide excision repair alone, 
as it is currently understood, is unable to account for the repair of these complex lesions. 
The linkage of both DNA strands to the lesion implies that the normal NER process of 
displacing the damaged region and resynthesis of cannot occur, since no template strand 
is available for synthesis. To accommodate this repair, two primary models for 
interstrand crosslink repair have been proposed (7, 11, 12) . Both propose that the 
nucleotide excision repair initiates the process, but then speculate that other repair 
pathways, such as recombination or translesion synthesis are coupled to excision repair to 
complete repair of the second strand through a multistep, multipathway process (7, 8, 11, 
12). 
The first model for ICL repair couples the NER pathway to recombination and is 
based primarily on early in vitro characterizations (13-17). In this model, the UvrABC 
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enzyme makes the initial 3’ and 5’ incisions on the furan side of interstrand crosslink. 
Then, the 3’ →5’ exonuclease activity of DNA polymerase I forms a gap creating a 
single strand region in which RecA, the central enzyme involved in homologous 
recombination, binds and promotes strand exchange with a homologous daughter 
chromosome (18, 19). The strand exchange enables UvrABC to make a second incision 
on the other strand (pyrone side of the interstrand crosslink) (13-16). In theory, after this 
occurs, the crosslink could then be removed and the gap re-synthesized using the sister 
chromosome as a template. RecA-mediated homologous recombination is classically 
defined as initiating through one of two pathways in Escherichia coli, the RecFOR and 
RecBCD pathway (19-23) . In order for RecA protein to initiate strand exchange reaction, 
RecFOR or RecBCD proteins are thought to be necessary to assist RecA to bind 
substrates containing single strand regions or DNA ends, respectively (18, 24). Although 
it is well established that RecA plays a role in surviving psoralen-induced damage, the 
comparative contributions of the RecFOR and RecBCD pathways is not known. 
However, an understanding of which pathway is involved would be useful and could 
suggest intermediates that arise in the repair process. 
In the absence of a daughter chromosome, homologous recombination cannot 
occur.  To account for this, an alternative model proposes that translesion systhesis may 
be coupled to NER. In this model, after the UvrA-B-C complex makes the initial 
incisions, the gap opposite to the lesion is resynthesized by translesion polymerases (11, 
25, 26). In principle, once this is accomplished, the UvrA-B-C complex could initiate a 
second round of incisions on the opposite strand and the damaged region could then be 
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removed and the gap resynthesized. 
 Escherichia coli contain three damage-inducible polymerases that participate in 
translesion synthesis. In vitro, polymerase II (Pol II) (polB), Pol IV (dinB), and Pol V 
(umuDC) are able to incorporate bases opposite to specific lesions in template DNA with 
higher efficiency than the replicative polymerase (27-34). Pol III and mutants lacking 
these genes have higher mutation rates in response to different forms of damage, 
suggesting that they operate similarly in vivo (27-34) . Supporting the translesion 
synthesis-dependent model of crosslink repair, the survival of plasmids containing 
interstrand crosslinks suggested that repair could occur independently from 
recombination and replication (26) .There are also conflicting reports about the 
hypersensitivity of some translesion polymerase mutants to crosslinking agents.  One 
group has reported multiple phenotypes for polymerase II (PolB), including 
hypersensitivity to nitrogen mustard, an agent that induces interstrand crosslinks among 
other lesions (25, 33, 34). However, subsequent studies have failed to confirm these PolB 
phenotypes (28, 35). Furthermore, a subsequent study reported that Pol IV, but not PolB, 
was able to synthesize past an oligo containing an acrolein interstrand crosslink in vitro 
(36). However, the role of the translesion polymerases has not been examined for 
psoralen-induced damage and no systematic study has examined all three polymerases for 
their contributions to survival in the presence of DNA interstrand crosslinks.  
In the second chapter, we reported the relative sensitivities of the NER pathway 
mutants to psoralen-induced damage and found that Cho contributes to the repair process 
with UvrC.  Here, we characterize and compare the relative contributions of the 
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recombination and translesion synthesis pathways in the survival of psoralen-induced 
damage to better understand the mechanism involved in the repair of these lesions. 
MATERIALS AND METHODS 
Bacterial Strains  
The parental strain used in this study was SR108, a thyA36 deoC2 derivative of 
W3110(37). Mutant strains HL952 lacking (SR108 uvrA::Tn10)(38), polB CL636 
(del(polB)::omega spc) (35), umuDC CL632 (UmuDC CL632) (35) ,dinB CL634 
(del(dinB)::Kan) (35).CL646 (SR108 polB::Ω Sm-Sp dinB::Kanr umuDC595::cat) (35), 
CL681 (SR108 polB:: Ω Sm-Sp dinB::Kanr umuDC595::cat uvrA::Tn10)(35), recA 
HL921 (recA::tetR) (38), recBC HL922 (tetR( recBC)) (38), and recF CL579 (SR108 
recF6206::Tetr) (38) have been previously reported. 
Psoralen UV-A Survival Assay 
Overnight cultures were grown in Davis medium supplemented with 0.4% 
glucose, 0.2% Casamino Acids, and 10μg/ml thymine (DGCthy). Subcultures were 
diluted 1:100 and grown at 37°C shaker in to an optical density at 600 nm (OD600) of 
0.3. At this time, 10µg/mL of psoralen was added to the cultures and incubation 
continued for five more minutes before irradiation with UV-A light. Cells were irradiated 
using two 32 watt UVA bulbs (Sylvanyia) with a peak emittance of (320 nm) at an 
incident dose of 6.9 J/m2/s. After irradiation, cells were serially diluted and 10 µl spots of 
each dilution were plated in triplicate onto LB thy agar plates. Plates were incubated at 
37°C and colonies were counted the next day to determine the surviving fraction.  
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RESULTS 
To examine how the two primary recombination pathways affect survival in the 
presence of psoralen-induced damage, we compared the survival of mutants defective in 
each pathway to the wild type strain and a recA strain, which is defective in all 
homologous recombination. To this end, 10μg/ml 8-methoxypsoralen was added to 
growing cultures of the parental and mutant strains before they were exposed to 
6.9/J/m2/s UVA irradiation for increasing time periods. The fraction of cells surviving to 
form colonies at each dose was then determined. Under these conditions, greater than 
37% of wild type cells survive UV-A doses up to ~3kJ/m2, which in the presence of 
10μg/ml 8-methoxypsoralen produces about 45-50 DNA crosslinks per genome (see Ch 
2, Figure 2-4). Although the level of monoadducts could not be determined from this 
data, these adducts are also likely to contribute to the lethality observed in the population. 
Consistent with earlier studies, recA mutants were highly sensitivity to psoralen-induced 
DNA damage, and survival was reduced to 37% with at dose ~0.5kJ/m2, which was 
similar to that of the nucleotide excision repair defective uvrA strain (Figure 3-1) under 
our conditions. This dose would correspond to approximately 7 crosslinks per genome, 
which is also similar to the lethal dose observed in previous studies (7) .We next 
examined the sensitivity of recF and recBC mutants. Both recBC and recF mutants were 
hypersensitive to psoralen-induced damage, relative to wild type cultures. However, the 
hypersensitivity of each mutant was more modest than that observed in recA cultures. At 
higher doses of UV-A light, recF cultures demonstrated slightly more sensitivity to 
psoralen-induced damage than recBC cultures. These results suggest that the repair of 
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psoralen-induced damage involves intermediates, or produces substrates that are 
processed by both the RecFOR and RecBCD pathways. 
 To examine the role of translesion synthesis in the repair of psoralen-induced 
DNA damage, we compared the survival of mutants that lack Pol II, Pol IV, Pol V, or all 
three of the damage inducible DNA polymerases in E. coli following treatment with 
psoralen plus UVA irradiation as before. Relative to wild type cultures, mutants lacking 
any single translesion polymerase were generally as resistant as wild type cultures at 
doses of irradiation below ~1 kJ/m2, but exhibited a modest hypersensitivity at higher 
doses (Figure 3-2). umuDC mutants, lacking Pol V, were significantly more sensitive 
than either polB (Pol II) or dinB (Pol IV) mutants.. The sensitivity of the triple 
polymerase mutant lacking all three damage-inducible DNA polymerases was similar to 
that of the umuDC (Pol V) single mutant, suggesting that Pol V is the predominant 
polymerase that contributes to survival at psoralen-induced DNA damage. 
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Figure 3-1. Both RecFOR and RecBCD pathways contribute to the survival of 
psoralen-induced DNA damage. The survival of cells following UV-A (340nm) 
irradiation in the presence of 10μg/ml 8-methoxy-psoralen is plotted. WT (open circles), 
recA (closed circles), recF (closed squares), recBC (closed triangles) Graphs represent 
the average of three or more independent experiments. Error bars represent one standard 
deviation. 
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Figure 3-2: Tranlesion Polymerase V, encoded by umuDC contributes to survival of 
psoralen-induced damage. The survival of cells following UV-A (340nm) irradiation in 
the presence of 10μg/ml 8-methoxy-psoralen is plotted. WT (open circles), umuDC 
(closed isosceles), polB-dinB-umuDC triple mutant (closed diamonds), dinB (closed 
squares) and polB (closed right triangle).  Graphs represent the average of three or more 
independent experiments. Error bars represent one standard deviation. 
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Figure 3-3: UvrA coupled with translesion polymerases increases the sensitivity for 
the psoralen induced lesions.  The survival of cells following UV-A (340nm) irradiation 
in the presence of 10μg/ml 8-methoxy-psoralen is plotted. WT (open circles), polB-dinB-
umuDC triple mutants (closed diamonds), polB-dinB-umuDC-uvrA quadraple mutant 
(closed isosceles), and uvrA (closed circles).Graphs represent the average of three or 
more independent experiments. Error bars represent one standard deviation. 
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I also compared the relative survival of the triple translesion polymerase mutants 
to that of the nucleotide excision repair, uvrA mutant. The hypersensitivity of the 
polymerase mutants was distinct from that of uvrA in that the polymerase mutants were 
not hypersensitive to low doses, and far less hypersensitive overall.  This could be 
interpreted to suggest that that primary contribution of translesion synthesis occurs when 
the level of DNA damage in the cell exceeds the capacity of the other repair pathways to 
deal with the lesions. Curiously, the absence of the translesion polymerases modestly 
increased the resistance of the uvrA mutant, although this mutant remained highly 
sensitive to psoralen-induced damage (Figure 3-3). This result could indicate that the 
absence of incisions that initiate repair benefits survival of cells in cases where the 
polymerases are not present. 
DISCUSSION 
 Current models of DNA interstrand crosslinks propose that coupling of multiple 
repair pathways are responsible for the repair of DNA interstrand crosslinks (Reviewed in 
(12)). One model suggested in the presence of replication, interstrand crosslinks are 
repaired by collaboration between NER and recombination proteins (7, 8, 39) . We 
demonstrated in our studies that both the RecF and RecBC recombination pathways are 
required for full resistance to psoralen-induced lesions. Although both pathways 
exhibited hypersensitivity, the higher sensitivity of the RecFOR pathway may suggest a 
role for this replication-associated recombination during the repair process.  A significant 
limitation of this study is that 8-methoxy psoralen induces both DNA interstrand 
crosslinks and monoadducts. Both the recFOR and recBCD pathways are known to by 
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hypersensitive to a variety of agents that produce monoadducts, thus, although we can 
conclude that these pathways contribute to the repair of psoralen-induced damage, we 
cannot say whether they contribute to DNA interstrand crosslinks. 
 A second model of crosslink repair suggests that the repair process couples 
NER with translesion synthesis pathways. According to the model, translesion 
polymerases assist in bypassing the displaced lesion-containing oligo that remains after 
the NER proteins make the first incision (11, 12, 25). A prediction of this model is that 
the translesion polymerases should be required for the survival of cells containing DNA 
interstrand crosslinks similar to that of the nucleotide excision repair mutants. However, 
while we observed that translesion polymerases contributed to cell survival of UVA 
irradiated cultures treated with psoralen treated , particularly  with respect to Pol V 
(umuDC), the survival curve was distinct from that the excision repair mutants in several 
ways.  In contrast to uvrA, the absence of the polymerases did not affect survival at lower 
levels of psoralen-induced  damage, and the overall hypersensitivity of the polymerase 
mutants was much less than that of the uvrA mutants.  These results would suggest that 
the polymerase mutants are not acting in the same pathway as nucleotide excision repair 
in removing these lesions as proposed.  Although as noted above, we cannot distinguish 
between the contributions of the polymerases have in tolerating monoadducts from that of 
interstrand crosslinks, the differences between the uvrA and polymerase mutant survivals 
allow us to infer that they are not acting in a single linear repair pathway. 
 In future work, it may prove informative to compare the survival curves of these 
strains using both 8-methoxypsoralen and angelicin, similar to the approach used for the 
  
 
64 
Cho mutant. This may allow us to differentiate which of these pathways and genes 
contribute to the repair of monoadducts and DNA interstrand crosslinks. 
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APPENDIX 
ROLE OF BASE EXCISION REPAIR PATHWAY AND NER ACCESSORY 
PROTEINS IN SURVIVAL OF DNA INTERSTRAND CROSSLINKS 
 UvrD is the helicase associated with nucleotide excision repair. Following dual 
incisions by UvrABC, UvrD displaces the oligo containing the lesion (1), well as the 
Nucleotide Excision Repair Complex that is bound to the lesion (2). I compared the 
survival of uvrD mutants to that of wildtype and other nucleotide excision repair mutants 
following psoralen- and UV-induced DNA damage. 
  
 
Figure 1: uvrD is less sensitive to psoralen- and UV-induced damage than other 
components of nucleotide excision repair.  The survival of cells following irriadiation 
with (A) UV-A light (340nm) in the presence of 10μg/ml 8-methoxy-psoralen or (B) 
UVC light (254nm) is plotted. WT (open circles), uvrA (closed circles), uvrB (closed 
square), uvrC (closed triangles) and uvrD (closed diamonds).Graphs represent the 
average of three independent experiments. Error bars represent one standard deviation. 
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 Irradiation with UVA by itself is known to generate significant levels of oxygen 
free radicals that lead to oxidative DNA damage (3) and mutants lacking Exonuclease III 
(xth) or Endonuclease IV are hypersensitive to oxidative DNA damage (4).To assess 
whether the level of oxidative DNA damage generated by the irradiation conditions used 
in this study could be contributing to the lethality observed on our various strains, we 
compared the survival of xth and nfo mutants to wild type cultures. 
 
 
Figure 2: Under the conditions used in this study, nfo and xth mutants are as 
resistant to psoralen-induced damage as wildtype cultures. The survival of cells 
following irriadiation with UV-A light (340nm) in the presence of 10μg/ml 8-methoxy-
psoralen is plotted..WT (open circles), nfo (closed circles) and xth (open square).Graphs 
represent the average of three independent experiments. Error bars represent one standard 
deviation. 
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